SAN DIEGO, Sept. 9, 2020 /PRNewswire/ -- BCTG Acquisition
Corp. (Nasdaq: BCTG) (the "Company") announced today that on
September 8, 2020 it closed its
initial public offering of 16,675,000 shares of common stock,
including 2,175,000 shares issued pursuant to the full exercise by
the underwriter of its over-allotment option. The offering
was priced at $10.00 per share,
resulting in gross proceeds of $166,750,000.
The Company is a special purpose acquisition company formed for
the purpose of effecting a business combination with one or more
businesses in the biotechnology sector. While the Company may
pursue an initial business combination target in any therapeutic
area, it intends to focus on opportunities in targeted
oncology. The Company, sponsored by Boxer Capital, LLC, is
led by Aaron Davis as Chief
Executive Officer and Chairman, Christopher
Fuglesang as President, Michael
Beauchamp as Chief Financial Officer and Andrew Ellis as Chief Operating Officer.
The Company's common stock began trading on The Nasdaq Capital
Market under the ticker symbol "BCTG" on September 3, 2020.
SVB Leerink is acting as sole bookrunning manager for the
offering.
The offering is being made only by means of a prospectus. Copies
of the prospectus may be obtained from: SVB Leerink LLC, Attention:
Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at
1-800-808-7525, ext. 6218, or by email at
syndicate@svbleerink.com.
Registration statements relating to these securities became
effective on September 2, 2020. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such an
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or
jurisdiction.
Forward-Looking Statements
This press release contains statements that constitute
"forward-looking statements," including with respect to the
proposed initial public offering and the anticipated use of the net
proceeds. No assurance can be given that the offering discussed
above will be completed on the terms described, or at all, or that
the net proceeds of the offering will be used as indicated.
Forward-looking statements are subject to numerous conditions, many
of which are beyond the control of the Company, including those set
forth in the Risk Factors section of the Company's final prospectus
for the Company's offering filed with the Securities and Exchange
Commission (the "SEC"). Copies are available on the SEC's website,
www.sec.gov. The Company undertakes no obligation to update these
statements for revisions or changes after the date of this release,
except as required by law.
Contact
BCTG Acquisition Corp.
Christina Martinez
(858) 400-3132
View original
content:http://www.prnewswire.com/news-releases/bctg-acquisition-corp-sponsored-by-boxer-capital-llc-announces-closing-of-166-8-million-initial-public-offering-including-the-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-301126371.html
SOURCE BCTG Acquisition Corp.